| 查看: 1049 | 回复: 9 | ||
| 【奖励】 本帖被评价7次，作者soochow增加金币 6.5 个 | ||
| 当前主题已经存档。 | ||
[资源]
【资源】聚合物治疗【 Advanced Drug Delivery Reviews专辑】
|
||
|
Advanced Drug Delivery Reviews 上最新一期关于聚合物用于治疗的专辑，希望感兴趣的朋友喜欢。 Volume 61, Issue 13, Pages 1117-1232 (12 November 2009) Polymer Therapeutics: Clinical Applications and Challenges for Development Edited by M.J. Vicent and R. Duncan http://www.sciencedirect.com/sci ... 9-999389986-1536091 附上一篇全文下载 Functional polymers as therapeutic agents: Concept to market place http://www.namipan.com/d/ADDR%202009-61-1121%20Functional%20polymers%20as%20therapeutic%20agents-Concept%20to%20market%20place.pdf/20e03168e4a6ecc1adcdbd5364e68749375a0dfceee00600 Preface 2. Polymer therapeutics: Clinical applications and challenges for development Pages 1117-1120 María J. Vicent, Helmut Ringsdorf, Ruth Duncan Biologically Active Polymers 3. Functional polymers as therapeutic agents: Concept to market place Pages 1121-1130 Pradeep K. Dhal, Steven C. Polomoscanik, Louis Z. Avila, S. Randall Holmes-Farley, Robert J. Miller Polymer Anticancer Conjugates 4. Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt Pages 1131-1148 Ruth Duncan 5. Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates Pages 1149-1158 nBlanka Rihova 6. Design and development of polymer conjugates as anti-angiogenic agents Pages 1159-1176 Ehud Segal, Ronit Satchi-Fainaro 7. PEG conjugates in clinical development or use as anticancer agents: An overview Pages 1177-1188 Gianfranco Pasut, Francesco M. Veronese 8. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin Pages 1189-1192 Mark E. Davis 9. XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer Pages 1193-1202 Alexander V. Yurkovetskiy, Robert J. Fram 10. Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines Pages 1203-1213 Francesca Greco, María J. Vicent 11. ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic Pages 1214-1219 David P Nowotnik, Esteban Cvitkovic Key Issues for Transfer from Lab to Clinic 12. Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics Pages 1220-1231 Rogério Gaspar, Ruth Duncan |
回复此楼» 猜你喜欢
08开头
已经有0人回复
-
中科中山药物创新研究院（药创院）怎么样？
已经有0人回复
-
生物物理、生物化学与分子生物学论文润色/翻译怎么收费?
已经有297人回复
-
4月19日晚八点前填系统 广西医科大学医学生物化学与分子生物学招生信息
已经有3人回复
2楼2009-10-21 20:07:30
3楼2009-10-22 11:02:14
4楼2009-10-22 17:15:19
5楼2009-10-23 07:39:55
6楼2009-10-23 08:16:10
7楼2009-10-23 11:58:37
8楼2009-10-23 12:07:46
10楼2009-10-23 15:02:46
简单回复
2009-10-23 12:30
回复
谢谢分享！
5